NCT03503240
Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery
Enrolling by Invitation
Not specifiedAges 21+ObservationalMemorial Sloan Kettering Cancer CenterInvestigator-initiated
~3,000 participants
Updated 2026-05-06 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
number of patients satisfied with facial appearance
Measured over 1 year
+1 more outcome measured
Conditions
Where it's being run
5 sites across 5 statesCalifornia1
Massachusetts1
Nebraska1
New York1
Texas1
Study leadership
- Erica Lee, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients ≥ 18 years of age at the time of surgery.
Had a diagnosis of a cutaneous malignancy
Cutaneous malignancy includes, but is not limited to basal cell carcinoma, squamous cell carcinoma, and melanoma
Able to speak and read English
MSK Only Cross Sectional Study: Radiation therapy patients ≥ 18 years of age who have received RT for skin cancer
Exclusion
Unable to speak and read English
What this trial measures
- number of patients satisfied with facial appearance1 year
Satisfaction with Facial Appearance Scale, Appearance-related Psychosocial Distress Scale and Adverse Effects Checklist using the FACE-Q Skin Cancer instrument.
- number of patients satisfied with scar outcome1year
Appraisal of Scars Scale, Appearance-related Psychosocial Distress Scale and Adverse Effects Checklist using the FACE-Q Skin Cancer instrument.